Search

everythinglearnresearchcommunity

for

Search:↓

E6/E7 oncogenes in hair follicles cause continuous hair growth by skipping the resting phase.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Targeting EGFR may help reduce hair loss from chemotherapy.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

CXCR2 in skin cells promotes tumor growth.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Provenge extends prostate cancer survival by about 4 months.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

mTOR may link different pathways in hair follicle tumor formation.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

High levels of ornithine decarboxylase can cause tumors in mouse skin.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Etoposide makes radiation therapy more effective against tumors without major side effects.